Back

Decreased retinal vascular complexity is an early biomarker of MI supported by a shared genetic control.

Villaplana Velasco, A.; Engelmann, J.; Rawlik, K.; Canela-Xandri, O.; Tochel, C.; Lona-Durazo, F.; Mookiah, M. R. K.; Doney, A.; Parra, E.; Trucco, E.; Macgillivray, T.; Rannikmae, K.; Tenesa, A.; Pairo-Castineira, E.; Bernabeu, M. O.

2021-12-16 health informatics
10.1101/2021.12.16.21267446
Show abstract

There is increasing evidence that the complexity of the retinal vasculature (measured as fractal dimension, Df) might offer earlier insights into the progression of coronary artery disease (CAD) before traditional biomarkers can be detected. This association could be partly explained by a common genetic basis; however, the genetic component of Df is poorly understood. We present here a genome-wide association study (GWAS) aimed to elucidate the genetic component of Df and to analyse its relationship with CAD. To this end, we obtained Df from retinal fundus images and genotyping information from [~]38,000 white-British participants in the UK Biobank. We discovered 9 loci associated with Df, previously reported in pigmentation, retinal width and tortuosity, hypertension, and CAD studies. Significant negative genetic correlation estimates endorse the inverse relationship between Df and CAD, and between Df and myocardial infarction (MI), one of CAD fatal outcomes. This strong association motivated us to developing a MI predictive model combining clinical information, Df, a CAD polygenic risk score and using a random forest algorithm. Internal cross validation evidenced a considerable improvement in the area under the curve (AUC) of our predictive model (AUC=0.770) when comparing with an established risk model, SCORE, (AUC=0.719). Our findings shed new light on the genetic basis of Df, unveiling a common control with CAD, and highlights the benefits of its application in individualised MI risk prediction.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Nature Communications
based on 483 papers
Top 1%
18.6%
2
Scientific Reports
based on 701 papers
Top 17%
9.1%
3
Communications Biology
based on 36 papers
Top 0.1%
5.8%
4
BMC Medical Genomics
based on 12 papers
Top 0.1%
4.9%
5
Bioinformatics
based on 24 papers
Top 0.4%
2.8%
6
GeroScience
based on 22 papers
Top 0.6%
2.7%
7
PLOS Genetics
based on 39 papers
Top 1%
2.5%
8
Journal of Personalized Medicine
based on 17 papers
Top 0.3%
2.5%
9
Communications Medicine
based on 63 papers
Top 0.3%
2.5%
50% of probability mass above
10
Circulation: Genomic and Precision Medicine
based on 30 papers
Top 3%
2.0%
11
Cell Genomics
based on 34 papers
Top 2%
1.7%
12
Ophthalmology Science
based on 15 papers
Top 1.0%
1.7%
13
Science Advances
based on 52 papers
Top 1%
1.7%
14
Cell Reports Medicine
based on 49 papers
Top 3%
1.4%
15
Nature Genetics
based on 72 papers
Top 6%
1.4%
16
PLOS ONE
based on 1737 papers
Top 90%
1.4%
17
PLOS Digital Health
based on 88 papers
Top 10%
1.3%
18
Science Translational Medicine
based on 40 papers
Top 3%
1.3%
19
Journal of the American College of Cardiology
based on 11 papers
Top 2%
0.9%
20
eLife
based on 262 papers
Top 26%
0.9%
21
Nature Medicine
based on 88 papers
Top 13%
0.9%
22
Clinical and Translational Science
based on 14 papers
Top 2%
0.9%
23
eBioMedicine
based on 82 papers
Top 7%
0.7%
24
Frontiers in Cardiovascular Medicine
based on 33 papers
Top 6%
0.7%
25
NeuroImage: Clinical
based on 77 papers
Top 8%
0.7%
26
Journal of the American Medical Informatics Association
based on 53 papers
Top 7%
0.7%
27
Atherosclerosis
based on 16 papers
Top 4%
0.7%
28
European Respiratory Journal
based on 44 papers
Top 6%
0.7%
29
The Lancet Digital Health
based on 25 papers
Top 5%
0.7%